Literature DB >> 18394620

The use and effectiveness of in vitro fertilization in women with endometriosis: the surgeon's perspective.

Edgardo Somigliana1, Raffaella Daguati, Paolo Vercellini, Giussy Barbara, Laura Benaglia, Pier Giorgio Crosignani.   

Abstract

OBJECTIVE: To assess the use and effectiveness of IVF in a cohort of women undergoing surgery for endometriosis.
DESIGN: Cohort study.
SETTING: University hospital. PATIENT(S): Four hundred thirty-eight patients who attempted to become pregnant after conservative surgery for endometriosis. INTERVENTION(S): Interview. MAIN OUTCOME MEASURE(S): Pregnancy and IVF use. RESULT(S): One hundred ninety-four women conceived in vivo (44%). One hundred twenty-four women did not undergo IVF despite their infertility status (51% of the group of women who failed to conceive in vivo). One hundred thirty-nine women underwent at least one IVF attempt. The cumulative rate of IVF use at 36 months of infertility was 33%. The live-birth/ongoing pregnancy rate per started cycle and per patient was 10% and 20%, respectively. CONCLUSION(S): In a large tertiary care and referral center, IVF played only a minor role in the treatment of endometriosis-associated infertility.

Entities:  

Mesh:

Year:  2008        PMID: 18394620     DOI: 10.1016/j.fertnstert.2008.02.004

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  2 in total

1.  Safe multidisciplinary approach in deeply infiltrating endometriosis (DIE): is it feasible?

Authors:  Ivete de Ávila; Luciana M P Costa; Mario Soto; Ivone D S Filogônio; Márcia M Carneiro
Journal:  JBRA Assist Reprod       Date:  2014-12-27

Review 2.  Oocyte Cryopreservation in Patients with Endometriosis: Current Knowledge and Number Needed to Treat.

Authors:  Laurie Henry; Julie Vervier; Astrid Boucher; Géraldine Brichant; Olivier Gaspard; Soraya Labied; Carine Munaut; Stéphanie Ravet; Michelle Nisolle
Journal:  J Clin Med       Date:  2022-08-04       Impact factor: 4.964

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.